‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse] 김새미 2025.08.27 오전 10:30 Samsung Bioepis, Boryung Partner on Bone Disorder Biosimilar ‘Exbrick’ 김새미 2025.07.02 오후 09:58 Investor Caution Urged as Adbiotech Hits Limit-Up on Ownership Change[K-bio pulse] 김승권 2025.06.12 오전 07:36 로딩중..
PhramEdaily
PhramEdaily
![‘Keytruda SC’ FDA Approval…Obesity Drug Battle in Europe[Monthly K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25082700487b.jpg)
![Investor Caution Urged as Adbiotech Hits Limit-Up on Ownership Change[K-bio pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/06/PS25061200420b.jpg)